When is it Not Gestational Diabetes? | Recording-When is it Not Gestational Diabetes?

Video Transcription

Video Summary

The webinar conducted by the ADA Pregnancy and Reproductive Health Interest Groups, led by Dr. Grainne O'Malley and Dr. Cassandra Henderson, focused on the complexities of diabetes, particularly gestational diabetes, latent autoimmune diabetes in adults (LADA), and monogenic diabetes during pregnancy. The session began with pivotal updates and reminders about continuing education credits available for participants. Dr. Celeste P. Durnwall presented on LADA’s unique clinical attributes, emphasizing its diagnosing challenges due to overlapping characteristics with type 1 and type 2 diabetes. She highlighted key identifiers, such as patient age, BMI, and the need for early insulin, and stressed the vital role of antibody testing, particularly the GAD antibody, to confirm diagnoses. Following that, Dr. Laura Dickens discussed monogenic diabetes, specifically focusing on its different forms like GCK, HNF1-alpha, and HNF4-alpha, commonly categorized as MODY. She detailed their genetic basis, presentation, and especially the nuances of managing these conditions during pregnancy. Emphasis was placed on the precision therapy required, highlighting how sulfonylureas can effectively manage glycemia in certain MODY types. The session also explored how individualized treatment and prenatal testing can advance care for such pregnancies. Overall, the discussion underscored the necessity for meticulous evaluation, diagnosis, and monitoring strategies tailored to the distinctive needs of pregnant patients facing diverse forms of diabetes. Participants were encouraged to remain engaged with the ADA community, utilizing its resources to enhance knowledge and professional growth.

Keywords

gestational diabetes

latent autoimmune diabetes

monogenic diabetes

pregnancy

MODY

antibody testing

precision therapy

sulfonylureas

individualized treatment

ADA community